
|Articles|March 1, 2003
Rx Dilemma
How much is too much to pay for a new dermatological drug? Your answer likely will depend on whether you're a developer or doctor, a patient or a third-party payer. Regardless of one's perspective, it doesn't take a medical degree to recognize the fact that prescription prices have risen precipitously in recent years, a trend which continued in 2002 and is expected to persist well beyond this year.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
2
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
3
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
4
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
5











